Gene therapy insertional mutagenesis insights. Davé UP, Jenkins NA, Copeland NG (2004) Science 303: 333 The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Liu G, Burns S, Huang G, Boyd K, Proia RL, Flavell RA, Chi H (2009) Nat Immunol 10: 769-77 Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effects. Sosman JA, Weiss GR, Margolin KA, Aronson FR, Sznol M, Atkins MB, O'Boyle K, Fisher RI, Boldt DH, Doroshow J (1993) J Clin Oncol 11: 1496-505 In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway disease. Youn J, Chen J, Goenka S, Aronica MA, Mora AL, Correa V, Sheller JR, Boothby M (1998) J Exp Med 188: 1803-16 Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. Boesteanu A, Silva AD, Nakajima H, Leonard WJ, Peschon JJ, Joyce S (1997) J Exp Med 186: 331-6 Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, Zlotnik A, Bennett M, Kumar V (1997) J Exp Med 186: 1609-14 Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats. Love LA, Rader JI, Crofford LJ, Raybourne RB, Principato MA, Page SW, Trucksess MW, Smith MJ, Dugan EM, Turner ML (1993) J Clin Invest 91: 804-11 Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients. McDonald DR, Goldman F, Gomez-Duarte OD, Issekutz AC, Kumararatne DS, Doffinger R, Geha RS (2010) J Allergy Clin Immunol 126: 332-7, 337.e1-2 Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. Aronica MA, McCarthy S, Swaidani S, Mitchell D, Goral M, Sheller JR, Boothby M (2004) Am J Respir Crit Care Med 169: 587-95 Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, Beeton C, Torossian S, Tatarian GG, Lee SU, Lau K, Walker E, Siminovitch KA, Chandy KG, Yu Z, Dennis JW, Demetriou M (2011) Nat Commun 2: 334 Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ (1996) Proc Natl Acad Sci U S A 93: 5275-80 The effects of the dialysis membrane on cytokine release. Zaoui P, Hakim RM (1994) J Am Soc Nephrol 4: 1711-8 Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I (2005) J Am Soc Nephrol 16: 1013-23 Podocyte injury damages other podocytes. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) J Am Soc Nephrol 22: 1275-85 Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype. Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM (1990) Cancer Res 50: 2683-91 Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Motoyoshi Y, Matsusaka T, Saito A, Pastan I, Willnow TE, Mizutani S, Ichikawa I (2008) Kidney Int 74: 1262-9 Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Zaoui P, Green W, Hakim RM (1991) Kidney Int 39: 1020-6 A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function. Pearson T, Shultz LD, Lief J, Burzenski L, Gott B, Chase T, Foreman O, Rossini AA, Bottino R, Trucco M, Greiner DL (2008) Diabetologia 51: 1449-56 An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice. Kaul V, Bhattacharya D, Singh Y, Van Kaer L, Peters-Golden M, Bishai WR, Das G (2012) J Infect Dis 206: 1816-25 Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, D'Aquila RT, Unutmaz D, Benson CA, Ritchie MD, Landay A, AIDS Clinical Trials Group (2006) J Infect Dis 194: 1098-107 Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD (2005) J Immunol 175: 7898-904 NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. Mora A, Youn J, Keegan A, Boothby M (2001) J Immunol 166: 2218-27 CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, Van Kaer L, Ljunggren HG, Chambers BJ (2000) J Immunol 165: 3673-9 Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2R beta/IL-4R alpha chimeric cytokine receptor transgene. Chen Y, Rosloniec E, Goral MI, Boothby M, Chen J (2001) J Immunol 166: 4163-9 Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. Lee MK, Moore DJ, Jarrett BP, Lian MM, Deng S, Huang X, Markmann JW, Chiaccio M, Barker CF, Caton AJ, Markmann JF (2004) J Immunol 172: 6539-44 IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. Casey LS, Lichtman AH, Boothby M (1992) J Immunol 148: 3418-26 CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. Trani J, Moore DJ, Jarrett BP, Markmann JW, Lee MK, Singer A, Lian MM, Tran B, Caton AJ, Markmann JF (2003) J Immunol 170: 279-86 Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Brehm MA, Powers AC, Shultz LD, Greiner DL (2012) Cold Spring Harb Perspect Med 2: a007757 Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. Daly S, Rinewalt D, Fhied C, Basu S, Mahon B, Liptay MJ, Hong E, Chmielewski G, Yoder MA, Shah PN, Edell ES, Maldonado F, Bungum AO, Borgia JA (2013) J Thorac Oncol 8: 31-6 T-reg mediated suppression of the allograft response in the draining lymph node. Lee MK, Moore DJ, Chiaccio M, Lian MM, Deng S, Mohiuddin M, Huang X, Koeberlein B, Zakheim A, Porrett PM, Barker CF, Caton AJ, Markmann JF (2006) Transplantation 81: 1063-6 Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation. Voss SD, Hank JA, Nobis CA, Fisch P, Sosman JA, Sondel PM (1989) Cancer Immunol Immunother 29: 261-9 A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Aslibekyan S, Kabagambe EK, Irvin MR, Straka RJ, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Shen J, Lai CQ, Ordovas JM, Arnett DK (2012) Pharmacogenet Genomics 22: 191-7 Lymphokine-dependent proliferation of T-lymphoid cells: regulated responsiveness and role in vivo. Boothby M, Mora AL, Stephenson LM (2001) Crit Rev Immunol 21: 487-522 Human recombinant interleukin 2-activated sheep lymphocytes lyse sheep pulmonary microvascular endothelial cells. Duke SS, King LS, Jones MR, Newman JH, Brigham KL, Forbes JT (1989) Cell Immunol 122: 188-99
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.